Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Demand and Key Producers, 2022-2028
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody is an unconjugated antibody to CEACAM5 (CD66e).
This report studies the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody that contribute to its increasing demand across many markets.
The global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody total production and demand, 2017-2028, (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody total production value, 2017-2028, (USD Million)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody domestic production, consumption, key domestic manufacturers and share
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market based on the following parameters – headquarters, production locations, products portfolio, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market, By Region:
1. How big is the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
2. What is the demand of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
3. What is the year over year growth of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
4. What is the production and production value of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
5. Who are the key producers in the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
6. What are the growth factors driving the market demand?
This report studies the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody that contribute to its increasing demand across many markets.
The global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody total production and demand, 2017-2028, (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody total production value, 2017-2028, (USD Million)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody domestic production, consumption, key domestic manufacturers and share
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market based on the following parameters – headquarters, production locations, products portfolio, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Monoclonal Antibody
- Polyclonal Antibody
- Flow Cytometry
- ELISA
- Western Blot
- Immunoprecipitation
- Other
- Sino Biological, Inc.
- LifeSpan BioSciences, Inc
- ??Abcam
- Thermo Fisher Scientific (China) Co., Ltd.
- Bio-Techne
- Boster Biological Technology
- Merck
- RayBiotech, Inc.
- Assay Genie
- Creative Biolabs
- MyBiosource, Inc.
- OriGene Technologies, Inc.
- Creative Diagnostics
- Abbexa
- Biorbyt
- Abeomics Inc.
- CUSABIO
- Enzo Life Sciences, Inc.
1. How big is the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
2. What is the demand of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
3. What is the year over year growth of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
4. What is the production and production value of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
5. Who are the key producers in the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Introduction
1.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Supply & Forecast
1.2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value (2017 & 2021 & 2028)
1.2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.2.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Pricing Trends (2017-2028)
1.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region
1.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017-2028)
1.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2017-2028)
1.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2017-2028)
1.3.4 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.6 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.7 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Demand (2017-2028)
2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region
2.2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region (2017-2022)
2.2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Forecast by Region (2023-2028)
2.3 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.4 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.6 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.7 South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.8 ASEAN Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.9 India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
3 WORLD CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Manufacturer (2017-2022)
3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Manufacturer (2017-2022)
3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturer (2017-2022)
3.4 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
3.5.3 Global Concentration Ratios (CR8) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
3.6 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Overall Company Footprint Analysis
3.6.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Region Footprint
3.6.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Type Footprint
3.6.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison
4.1.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison
4.2.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison
4.3.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
4.5 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2017-2028)
5.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2017-2028)
5.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Flow Cytometry
6.2.2 ELISA
6.2.3 Western Blot
6.2.4 Immunoprecipitation
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2017-2028)
6.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2017-2028)
6.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.1.4 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Details
7.2.2 LifeSpan BioSciences, Inc Major Business
7.2.3 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.2.4 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 LifeSpan BioSciences, Inc Recent Developments/Updates
7.2.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
7.3 ??Abcam
7.3.1 ??Abcam Details
7.3.2 ??Abcam Major Business
7.3.3 ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.3.4 ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 ??Abcam Recent Developments/Updates
7.3.6 ??Abcam Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific (China) Co., Ltd.
7.4.1 Thermo Fisher Scientific (China) Co., Ltd. Details
7.4.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
7.4.3 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.4.4 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
7.4.6 Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
7.5 Bio-Techne
7.5.1 Bio-Techne Details
7.5.2 Bio-Techne Major Business
7.5.3 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.5.4 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bio-Techne Recent Developments/Updates
7.5.6 Bio-Techne Competitive Strengths & Weaknesses
7.6 Boster Biological Technology
7.6.1 Boster Biological Technology Details
7.6.2 Boster Biological Technology Major Business
7.6.3 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.6.4 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Boster Biological Technology Recent Developments/Updates
7.6.6 Boster Biological Technology Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.7.4 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 RayBiotech, Inc.
7.8.1 RayBiotech, Inc. Details
7.8.2 RayBiotech, Inc. Major Business
7.8.3 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.8.4 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 RayBiotech, Inc. Recent Developments/Updates
7.8.6 RayBiotech, Inc. Competitive Strengths & Weaknesses
7.9 Assay Genie
7.9.1 Assay Genie Details
7.9.2 Assay Genie Major Business
7.9.3 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.9.4 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Assay Genie Recent Developments/Updates
7.9.6 Assay Genie Competitive Strengths & Weaknesses
7.10 Creative Biolabs
7.10.1 Creative Biolabs Details
7.10.2 Creative Biolabs Major Business
7.10.3 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.10.4 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Creative Biolabs Recent Developments/Updates
7.10.6 Creative Biolabs Competitive Strengths & Weaknesses
7.11 MyBiosource, Inc.
7.11.1 MyBiosource, Inc. Details
7.11.2 MyBiosource, Inc. Major Business
7.11.3 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.11.4 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 MyBiosource, Inc. Recent Developments/Updates
7.11.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.12 OriGene Technologies, Inc.
7.12.1 OriGene Technologies, Inc. Details
7.12.2 OriGene Technologies, Inc. Major Business
7.12.3 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.12.4 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 OriGene Technologies, Inc. Recent Developments/Updates
7.12.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
7.13 Creative Diagnostics
7.13.1 Creative Diagnostics Details
7.13.2 Creative Diagnostics Major Business
7.13.3 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.13.4 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Creative Diagnostics Recent Developments/Updates
7.13.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.14 Abbexa
7.14.1 Abbexa Details
7.14.2 Abbexa Major Business
7.14.3 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.14.4 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Abbexa Recent Developments/Updates
7.14.6 Abbexa Competitive Strengths & Weaknesses
7.15 Biorbyt
7.15.1 Biorbyt Details
7.15.2 Biorbyt Major Business
7.15.3 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.15.4 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Biorbyt Recent Developments/Updates
7.15.6 Biorbyt Competitive Strengths & Weaknesses
7.16 Abeomics Inc.
7.16.1 Abeomics Inc. Details
7.16.2 Abeomics Inc. Major Business
7.16.3 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.16.4 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Abeomics Inc. Recent Developments/Updates
7.16.6 Abeomics Inc. Competitive Strengths & Weaknesses
7.17 CUSABIO
7.17.1 CUSABIO Details
7.17.2 CUSABIO Major Business
7.17.3 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.17.4 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 CUSABIO Recent Developments/Updates
7.17.6 CUSABIO Competitive Strengths & Weaknesses
7.18 Enzo Life Sciences, Inc.
7.18.1 Enzo Life Sciences, Inc. Details
7.18.2 Enzo Life Sciences, Inc. Major Business
7.18.3 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.18.4 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Enzo Life Sciences, Inc. Recent Developments/Updates
7.18.6 Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody and Key Manufacturers
8.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Manufacturing Costs
8.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Process
8.4 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Distributors
9.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Introduction
1.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Supply & Forecast
1.2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value (2017 & 2021 & 2028)
1.2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.2.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Pricing Trends (2017-2028)
1.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region
1.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017-2028)
1.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2017-2028)
1.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2017-2028)
1.3.4 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.6 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.3.7 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Demand (2017-2028)
2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region
2.2.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region (2017-2022)
2.2.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Forecast by Region (2023-2028)
2.3 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.4 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.6 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.7 South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.8 ASEAN Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
2.9 India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028)
3 WORLD CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Manufacturer (2017-2022)
3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Manufacturer (2017-2022)
3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturer (2017-2022)
3.4 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
3.5.3 Global Concentration Ratios (CR8) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
3.6 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Overall Company Footprint Analysis
3.6.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Region Footprint
3.6.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Type Footprint
3.6.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison
4.1.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison
4.2.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison
4.3.1 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
4.5 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2017-2028)
5.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2017-2028)
5.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Flow Cytometry
6.2.2 ELISA
6.2.3 Western Blot
6.2.4 Immunoprecipitation
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2017-2028)
6.3.2 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2017-2028)
6.3.3 World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.1.4 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Details
7.2.2 LifeSpan BioSciences, Inc Major Business
7.2.3 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.2.4 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 LifeSpan BioSciences, Inc Recent Developments/Updates
7.2.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
7.3 ??Abcam
7.3.1 ??Abcam Details
7.3.2 ??Abcam Major Business
7.3.3 ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.3.4 ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 ??Abcam Recent Developments/Updates
7.3.6 ??Abcam Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific (China) Co., Ltd.
7.4.1 Thermo Fisher Scientific (China) Co., Ltd. Details
7.4.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
7.4.3 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.4.4 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
7.4.6 Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
7.5 Bio-Techne
7.5.1 Bio-Techne Details
7.5.2 Bio-Techne Major Business
7.5.3 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.5.4 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bio-Techne Recent Developments/Updates
7.5.6 Bio-Techne Competitive Strengths & Weaknesses
7.6 Boster Biological Technology
7.6.1 Boster Biological Technology Details
7.6.2 Boster Biological Technology Major Business
7.6.3 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.6.4 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Boster Biological Technology Recent Developments/Updates
7.6.6 Boster Biological Technology Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.7.4 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 RayBiotech, Inc.
7.8.1 RayBiotech, Inc. Details
7.8.2 RayBiotech, Inc. Major Business
7.8.3 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.8.4 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 RayBiotech, Inc. Recent Developments/Updates
7.8.6 RayBiotech, Inc. Competitive Strengths & Weaknesses
7.9 Assay Genie
7.9.1 Assay Genie Details
7.9.2 Assay Genie Major Business
7.9.3 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.9.4 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Assay Genie Recent Developments/Updates
7.9.6 Assay Genie Competitive Strengths & Weaknesses
7.10 Creative Biolabs
7.10.1 Creative Biolabs Details
7.10.2 Creative Biolabs Major Business
7.10.3 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.10.4 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Creative Biolabs Recent Developments/Updates
7.10.6 Creative Biolabs Competitive Strengths & Weaknesses
7.11 MyBiosource, Inc.
7.11.1 MyBiosource, Inc. Details
7.11.2 MyBiosource, Inc. Major Business
7.11.3 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.11.4 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 MyBiosource, Inc. Recent Developments/Updates
7.11.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.12 OriGene Technologies, Inc.
7.12.1 OriGene Technologies, Inc. Details
7.12.2 OriGene Technologies, Inc. Major Business
7.12.3 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.12.4 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 OriGene Technologies, Inc. Recent Developments/Updates
7.12.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
7.13 Creative Diagnostics
7.13.1 Creative Diagnostics Details
7.13.2 Creative Diagnostics Major Business
7.13.3 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.13.4 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Creative Diagnostics Recent Developments/Updates
7.13.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.14 Abbexa
7.14.1 Abbexa Details
7.14.2 Abbexa Major Business
7.14.3 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.14.4 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Abbexa Recent Developments/Updates
7.14.6 Abbexa Competitive Strengths & Weaknesses
7.15 Biorbyt
7.15.1 Biorbyt Details
7.15.2 Biorbyt Major Business
7.15.3 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.15.4 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Biorbyt Recent Developments/Updates
7.15.6 Biorbyt Competitive Strengths & Weaknesses
7.16 Abeomics Inc.
7.16.1 Abeomics Inc. Details
7.16.2 Abeomics Inc. Major Business
7.16.3 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.16.4 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Abeomics Inc. Recent Developments/Updates
7.16.6 Abeomics Inc. Competitive Strengths & Weaknesses
7.17 CUSABIO
7.17.1 CUSABIO Details
7.17.2 CUSABIO Major Business
7.17.3 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.17.4 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 CUSABIO Recent Developments/Updates
7.17.6 CUSABIO Competitive Strengths & Weaknesses
7.18 Enzo Life Sciences, Inc.
7.18.1 Enzo Life Sciences, Inc. Details
7.18.2 Enzo Life Sciences, Inc. Major Business
7.18.3 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
7.18.4 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Enzo Life Sciences, Inc. Recent Developments/Updates
7.18.6 Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody and Key Manufacturers
8.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Manufacturing Costs
8.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Process
8.4 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Distributors
9.3 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017-2022) & (USD Million)
Table 3. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2023-2028) & (USD Million)
Table 4. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2017-2022)
Table 5. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2023-2028)
Table 6. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2017-2022) & (K Units)
Table 7. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2023-2028) & (K Units)
Table 8. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2017-2022)
Table 9. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2023-2028)
Table 10. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Major Market Trends
Table 13. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region (2017-2022) & (K Units)
Table 15. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Producers in 2021
Table 18. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Producers in 2021
Table 20. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Company Evaluation Quadrant
Table 22. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Site of Key Manufacturer
Table 24. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Type Footprint
Table 25. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Application Footprint
Table 26. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Competitive Factors
Table 27. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody New Entrant and Capacity Expansion Plans
Table 28. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Mergers & Acquisitions Activity
Table 29. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2017-2022) & (K Units)
Table 49. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2023-2028) & (K Units)
Table 50. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2017-2022) & (USD Million)
Table 51. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2023-2028) & (USD Million)
Table 52. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2017-2022) & (K Units)
Table 56. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2023-2028) & (K Units)
Table 57. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2017-2022) & (USD Million)
Table 58. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2023-2028) & (USD Million)
Table 59. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 64. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table 68. LifeSpan BioSciences, Inc Major Business
Table 69. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 70. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 72. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 73. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 74. ??Abcam Major Business
Table 75. ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 76. ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. ??Abcam Recent Developments/Updates
Table 78. ??Abcam Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific (China) Co., Ltd. Major Business
Table 81. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 82. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 84. Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
Table 85. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 86. Bio-Techne Major Business
Table 87. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 88. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bio-Techne Recent Developments/Updates
Table 90. Bio-Techne Competitive Strengths & Weaknesses
Table 91. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 92. Boster Biological Technology Major Business
Table 93. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 94. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Boster Biological Technology Recent Developments/Updates
Table 96. Boster Biological Technology Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 100. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. RayBiotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. RayBiotech, Inc. Major Business
Table 105. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 106. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. RayBiotech, Inc. Recent Developments/Updates
Table 108. RayBiotech, Inc. Competitive Strengths & Weaknesses
Table 109. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 110. Assay Genie Major Business
Table 111. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 112. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Assay Genie Recent Developments/Updates
Table 114. Assay Genie Competitive Strengths & Weaknesses
Table 115. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 116. Creative Biolabs Major Business
Table 117. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 118. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Creative Biolabs Recent Developments/Updates
Table 120. Creative Biolabs Competitive Strengths & Weaknesses
Table 121. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. MyBiosource, Inc. Major Business
Table 123. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 124. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. MyBiosource, Inc. Recent Developments/Updates
Table 126. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 127. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. OriGene Technologies, Inc. Major Business
Table 129. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 130. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. OriGene Technologies, Inc. Recent Developments/Updates
Table 132. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 133. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 134. Creative Diagnostics Major Business
Table 135. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 136. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Creative Diagnostics Recent Developments/Updates
Table 138. Creative Diagnostics Competitive Strengths & Weaknesses
Table 139. Abbexa Basic Information, Manufacturing Base and Competitors
Table 140. Abbexa Major Business
Table 141. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 142. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Abbexa Recent Developments/Updates
Table 144. Abbexa Competitive Strengths & Weaknesses
Table 145. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 146. Biorbyt Major Business
Table 147. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 148. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Biorbyt Recent Developments/Updates
Table 150. Biorbyt Competitive Strengths & Weaknesses
Table 151. Abeomics Inc. Basic Information, Manufacturing Base and Competitors
Table 152. Abeomics Inc. Major Business
Table 153. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 154. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Abeomics Inc. Recent Developments/Updates
Table 156. Abeomics Inc. Competitive Strengths & Weaknesses
Table 157. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 158. CUSABIO Major Business
Table 159. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 160. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. CUSABIO Recent Developments/Updates
Table 162. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 163. Enzo Life Sciences, Inc. Major Business
Table 164. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 165. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Raw Material
Table 167. Key Manufacturers of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Raw Materials
Table 168. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Distributors
Table 169. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Customers
Table 1. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2017-2022) & (USD Million)
Table 3. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Region (2023-2028) & (USD Million)
Table 4. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2017-2022)
Table 5. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2023-2028)
Table 6. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2017-2022) & (K Units)
Table 7. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Region (2023-2028) & (K Units)
Table 8. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2017-2022)
Table 9. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2023-2028)
Table 10. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Major Market Trends
Table 13. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption by Region (2017-2022) & (K Units)
Table 15. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Producers in 2021
Table 18. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Producers in 2021
Table 20. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Company Evaluation Quadrant
Table 22. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Site of Key Manufacturer
Table 24. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Type Footprint
Table 25. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Company Product Application Footprint
Table 26. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Competitive Factors
Table 27. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody New Entrant and Capacity Expansion Plans
Table 28. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Mergers & Acquisitions Activity
Table 29. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2017-2022) & (K Units)
Table 49. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Type (2023-2028) & (K Units)
Table 50. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2017-2022) & (USD Million)
Table 51. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type (2023-2028) & (USD Million)
Table 52. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2017-2022) & (K Units)
Table 56. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production by Application (2023-2028) & (K Units)
Table 57. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2017-2022) & (USD Million)
Table 58. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application (2023-2028) & (USD Million)
Table 59. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 64. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table 68. LifeSpan BioSciences, Inc Major Business
Table 69. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 70. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 72. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 73. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 74. ??Abcam Major Business
Table 75. ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 76. ??Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. ??Abcam Recent Developments/Updates
Table 78. ??Abcam Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific (China) Co., Ltd. Major Business
Table 81. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 82. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 84. Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
Table 85. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 86. Bio-Techne Major Business
Table 87. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 88. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bio-Techne Recent Developments/Updates
Table 90. Bio-Techne Competitive Strengths & Weaknesses
Table 91. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 92. Boster Biological Technology Major Business
Table 93. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 94. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Boster Biological Technology Recent Developments/Updates
Table 96. Boster Biological Technology Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 100. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. RayBiotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. RayBiotech, Inc. Major Business
Table 105. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 106. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. RayBiotech, Inc. Recent Developments/Updates
Table 108. RayBiotech, Inc. Competitive Strengths & Weaknesses
Table 109. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 110. Assay Genie Major Business
Table 111. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 112. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Assay Genie Recent Developments/Updates
Table 114. Assay Genie Competitive Strengths & Weaknesses
Table 115. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 116. Creative Biolabs Major Business
Table 117. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 118. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Creative Biolabs Recent Developments/Updates
Table 120. Creative Biolabs Competitive Strengths & Weaknesses
Table 121. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. MyBiosource, Inc. Major Business
Table 123. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 124. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. MyBiosource, Inc. Recent Developments/Updates
Table 126. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 127. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. OriGene Technologies, Inc. Major Business
Table 129. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 130. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. OriGene Technologies, Inc. Recent Developments/Updates
Table 132. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 133. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 134. Creative Diagnostics Major Business
Table 135. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 136. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Creative Diagnostics Recent Developments/Updates
Table 138. Creative Diagnostics Competitive Strengths & Weaknesses
Table 139. Abbexa Basic Information, Manufacturing Base and Competitors
Table 140. Abbexa Major Business
Table 141. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 142. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Abbexa Recent Developments/Updates
Table 144. Abbexa Competitive Strengths & Weaknesses
Table 145. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 146. Biorbyt Major Business
Table 147. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 148. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Biorbyt Recent Developments/Updates
Table 150. Biorbyt Competitive Strengths & Weaknesses
Table 151. Abeomics Inc. Basic Information, Manufacturing Base and Competitors
Table 152. Abeomics Inc. Major Business
Table 153. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 154. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Abeomics Inc. Recent Developments/Updates
Table 156. Abeomics Inc. Competitive Strengths & Weaknesses
Table 157. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 158. CUSABIO Major Business
Table 159. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 160. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. CUSABIO Recent Developments/Updates
Table 162. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 163. Enzo Life Sciences, Inc. Major Business
Table 164. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product and Services
Table 165. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Raw Material
Table 167. Key Manufacturers of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Raw Materials
Table 168. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Distributors
Table 169. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Typical Customers
LIST OF FIGURES
Figure 1. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Picture
Figure 2. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 5. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (2017-2028) & (US$/Unit)
Figure 6. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2017-2028)
Figure 7. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2017-2028)
Figure 8. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 9. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 10. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 11. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 12. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Demand (2017-2028) & (K Units)
Figure 15. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share by Region (2017-2028)
Figure 16. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 17. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 18. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 19. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 20. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 22. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Markets in 2021
Figure 26. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States
Figure 30. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China
Figure 31. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World
Figure 32. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Polyclonal Antibody
Figure 36. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Type (2017-2028)
Figure 37. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Type (2017-2028)
Figure 38. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Application in 2021
Figure 41. Flow Cytometry
Figure 42. ELISA
Figure 43. Western Blot
Figure 44. Immunoprecipitation
Figure 45. Other
Figure 46. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Application (2017-2028)
Figure 47. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Application (2017-2028)
Figure 48. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
Figure 50. Manufacturing Process Analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 51. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industrial Chain
Figure 52. Distribution Channel Breakdown for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Picture
Figure 2. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 5. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (2017-2028) & (US$/Unit)
Figure 6. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Region (2017-2028)
Figure 7. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2017-2028)
Figure 8. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 9. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 10. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 11. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2017-2028) & (K Units)
Figure 12. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Demand (2017-2028) & (K Units)
Figure 15. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share by Region (2017-2028)
Figure 16. United States Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 17. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 18. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 19. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 20. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 22. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Markets in 2021
Figure 26. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in United States
Figure 30. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in China
Figure 31. Key Producers and Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in Rest of World
Figure 32. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Polyclonal Antibody
Figure 36. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Type (2017-2028)
Figure 37. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Type (2017-2028)
Figure 38. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Application in 2021
Figure 41. Flow Cytometry
Figure 42. ELISA
Figure 43. Western Blot
Figure 44. Immunoprecipitation
Figure 45. Other
Figure 46. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Application (2017-2028)
Figure 47. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Value Market Share by Application (2017-2028)
Figure 48. World Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in 2021
Figure 50. Manufacturing Process Analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 51. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industrial Chain
Figure 52. Distribution Channel Breakdown for Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
